Literature DB >> 8034587

The secreted tumor-associated antigen 90K is a potent immune stimulator.

A Ullrich1, I Sures, M D'Egidio, B Jallal, T J Powell, R Herbst, A Dreps, M Azam, M Rubinstein, C Natoli.   

Abstract

Immunization of mice with conditioned media from human breast cancer cells yielded the monoclonal antibody SP-2, which recognized an antigen of approximately 90-95 kDa. This protein, designated 90K, was found to be present in the serum of healthy individuals and at elevated levels in the serum of subpopulations of patients with various types of cancer and AIDS. Here we report the primary structure of the SP-2 antigen and demonstrate its relationship to a family of proteins which carry a scavenger receptor cysteine-rich domain. Northern blot analysis of normal tissues, primary tumors, and tumor-derived cell lines indicates a broad expression spectrum of the 90K gene at widely varying levels. Functional characterization reveals stimulatory effects of 90K on host defense systems, such as natural killer cell and lymphokine-activated killer cell activity, and indicates that its immunostimulatory effects may be mediated through the induction of interleukin-2 and possibly other cytokines.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8034587

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  62 in total

1.  Variations in serum IL-7 and 90K/Mac-2 binding protein (Mac-2 BP) levels analysed in cohorts of HIV-1 patients and correlated with clinical changes following antiretroviral therapy.

Authors:  E C Darcissac; V Vidal; X De La Tribonniere; Y Mouton; G M Bahr
Journal:  Clin Exp Immunol       Date:  2001-11       Impact factor: 4.330

2.  Elevated levels of circulating immunostimulatory 90K in Henoch-Schoenlein purpura.

Authors:  P Pelliccia; C Natoli; M T Petitti; A Verrotti; F Chiarelli; S Iacobelli
Journal:  J Clin Immunol       Date:  1999-03       Impact factor: 8.317

3.  Exploration of the normal human bronchoalveolar lavage fluid proteome.

Authors:  Jinzhi Chen; Soyoung Ryu; Sina A Gharib; David R Goodlett; Lynn M Schnapp
Journal:  Proteomics Clin Appl       Date:  2008-04       Impact factor: 3.494

4.  Co-purification of Mac-2 binding protein with galectin-3 and association with prostasomes in human semen.

Authors:  Ashley S Block; Sarika Saraswati; Cheryl F Lichti; Maha Mahadevan; Alan B Diekman
Journal:  Prostate       Date:  2010-10-28       Impact factor: 4.104

5.  Integration of 18O labeling and solution isoelectric focusing in a shotgun analysis of mitochondrial proteins.

Authors:  Jinshan Wang; Peter Gutierrez; Nathan Edwards; Catherine Fenselau
Journal:  J Proteome Res       Date:  2007-11-10       Impact factor: 4.466

6.  Elevated plasma levels of 90K (Mac-2 BP) immunostimulatory glycoprotein in HIV-1-infected children.

Authors:  B Gröschel; J J Braner; M Funk; R Linde; H W Doerr; J Cinatl; S Iacobelli
Journal:  J Clin Immunol       Date:  2000-03       Impact factor: 8.317

7.  Human milk 90K (Mac-2 BP): possible protective effects against acute respiratory infections.

Authors:  B Fornarini; S Iacobelli; N Tinari; C Natoli; M De Martino; G Sabatino
Journal:  Clin Exp Immunol       Date:  1999-01       Impact factor: 4.330

8.  Quantitative Proteomics Reveals the Roles of Peroxisome-associated Proteins in Antiviral Innate Immune Responses.

Authors:  Mao-Tian Zhou; Yue Qin; Mi Li; Chen Chen; Xi Chen; Hong-Bing Shu; Lin Guo
Journal:  Mol Cell Proteomics       Date:  2015-06-29       Impact factor: 5.911

9.  Dendritic cell-based immunotherapy for colon cancer using an HLA-A*0201-restricted cytotoxic T-lymphocyte epitope from tumor-associated antigen 90K.

Authors:  Ji Hee Lee; Myong-Suk Park; Jun-Eul Hwang; Sang-Hee Cho; Woo-Kyun Bae; Hyun-Jeong Shim; Dae-Eun Kim; Ik-Joo Chung
Journal:  Cell Mol Immunol       Date:  2013-03-25       Impact factor: 11.530

10.  Cyclophilin C-associated protein (CyCAP) knock-out mice spontaneously develop colonic mucosal hyperplasia and exaggerated tumorigenesis after treatment with carcinogen azoxymethane.

Authors:  Emina Emilia Torlakovic; Vicki Keeler; Chang Wang; Hyun J Lim; Leslie Ann Lining; Suzanne Laferté
Journal:  BMC Cancer       Date:  2009-07-24       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.